D.Western Therapeutics Institute, Inc. Logo

D.Western Therapeutics Institute, Inc.

Biotech firm discovering and licensing drug candidates, focusing on kinase inhibitors.

4576 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
名古屋市中区錦一丁目18番11号
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

D.Western Therapeutics Institute, Inc. is a university-originated biotechnology venture focused on drug discovery and development. The company aims to create innovative and more effective drugs for patients worldwide by leveraging its core technology, which includes a proprietary compound library and specialized expertise in inhibitors, particularly protein kinases. Its business model centers on discovering and developing novel drug candidates before out-licensing them to larger pharmaceutical companies for late-stage clinical trials and commercialization. The company's development pipeline includes therapeutic drugs for various conditions, with a known focus in areas such as ophthalmology.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for D.Western Therapeutics Institute, Inc. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-14 08:45
Interim Report
半期報告書-第28期(2025/01/01-2025/12/31)
Japanese 175.2 KB
2025-08-14 08:45
Regulatory News Service
確認書
Japanese 8.2 KB
2025-07-15 08:30
Prospectus
有価証券届出書(組込方式)
Japanese 540.8 KB
2025-03-26 01:26
Regulatory News Service
臨時報告書
Japanese 25.8 KB
2025-03-25 07:31
Regulatory News Service
確認書
Japanese 8.2 KB
2025-03-25 07:30
Regulatory News Service
内部統制報告書-第27期(2024/01/01-2024/12/31)
Japanese 21.5 KB
2025-03-25 07:30
Annual Report
有価証券報告書-第27期(2024/01/01-2024/12/31)
Japanese 1.1 MB
2025-01-16 07:34
Regulatory News Service
臨時報告書
Japanese 18.4 KB
2025-01-10 02:55
Regulatory News Service
臨時報告書
Japanese 21.1 KB
2024-08-09 08:35
Regulatory News Service
確認書
Japanese 8.2 KB
2024-08-09 08:34
Interim Report
半期報告書-第27期(2024/01/01-2024/12/31)
Japanese 219.2 KB
2024-06-07 08:31
Regulatory News Service
臨時報告書
Japanese 19.3 KB
2024-05-17 08:01
Prospectus
有価証券届出書(組込方式)
Japanese 328.7 KB
2024-05-13 08:32
Regulatory News Service
確認書
Japanese 8.1 KB
2024-05-13 08:31
Quarterly Report
四半期報告書-第27期第1四半期(2024/01/01-2024/03/31)
Japanese 135.5 KB

Automate Your Workflow. Get a real-time feed of all D.Western Therapeutics Institute, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for D.Western Therapeutics Institute, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
PharmaLundensis AB Logo
Develops treatments for heavy metal toxicity and serious respiratory illnesses.
Sweden PHAL
PhoenixBio Co.,Ltd. Logo
CRO providing humanized liver mouse models and testing services for preclinical drug development.
Japan 6190
Plantarc Bio Ltd. Logo
Developing high-yield, resilient crops via gene discovery for global seed companies.
Israel PLNT
Polymetal International plc Logo
A top global gold and silver producer with mining and exploration operations in Kazakhstan.
Kazakhstan POLY
Poxel Logo
Develops drugs for metabolic diseases, including NASH, rare diseases, and an approved diabetes drug.
France POXEL
PRAP Japan,Inc. Logo
A PR & communications firm building brand reputation for corporate clients in diverse industries.
Japan 2449
Public Policy Holding Company, Inc. Logo
Advisory group providing public policy, government relations, and strategic communications services.
United States of America PPHC.L
Purple Biotech Ltd. Logo
Developing cancer therapies to overcome tumor immune evasion and drug resistance.
Israel PPBT
QUIA PHARMA AB Logo
Develops biobetters by enhancing approved drugs with a patented drug delivery platform.
Sweden QUIA
RaQualia Pharma Inc. Logo
An R&D firm discovering novel small molecules for out-licensing to pharma partners.
Japan 4579

Talk to a Data Expert

Have a question? We'll get back to you promptly.